犬常规抗生素治疗增加粪便耐药大肠埃希菌检出
该研究对127只接受五种抗生素之一治疗的犬,在治疗前、治疗后即刻、1个月和3个月采集457份粪便样本,用纸片扩散法和PCR检测耐药表型及基因,多水平模型分析显示β-内酰胺类或氟喹诺酮类治疗与治疗后即刻3GCR、AmpC、MDR和/或氟喹诺酮耐药大肠埃希菌检出显著相关。
要点
- β-内酰胺类或氟喹诺酮类常规治疗与犬粪便3GCR、AmpC、MDR和/或氟喹诺酮耐药大肠埃希菌检出增加相关。
- 治疗结束后1个月仅阿莫西林/克拉维酸与3GCR检出显著相关。
- 治疗结束后3个月各抗菌药物与治疗前相比无显著差异。
核心结论
- 犬接受β-内酰胺类或氟喹诺酮类常规治疗后,粪便中重要表型和基因型耐药大肠埃希菌检出增加。
研究设计与样本
- 纵向研究,采集127只犬的457份粪便样本,在治疗前、治疗后即刻、1个月和3个月检测。
- 五种抗菌药物分组,用纸片扩散法测耐药表型,PCR检测耐药基因,多水平模型分析危险因素。
主要发现
- β-内酰胺类或氟喹诺酮类治疗与治疗后即刻3GCR、AmpC、MDR和/或氟喹诺酮耐药大肠埃希菌检出显著相关,但与ESBL产生大肠埃希菌无关。
- 治疗结束后1个月,仅阿莫西林/克拉维酸与3GCR检出显著相关。
- 治疗结束后3个月,任何抗菌药物与治疗前相比均无显著差异。
临床怎么用
- 兽医处方抗菌药物时应考虑对粪便耐药菌检出的影响,并加强生物安全与犬粪便处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is a critical health problem, with systemic antimicrobial therapy driving development of AMR across the host spectrum. OBJECTIVES: This study compares longitudinal carriage, at multiple timepoints, of AMR faecal Escherichia coli in dogs undergoing routine antimicrobial treatment. METHODS: Faecal samples (n = 457) from dogs (n = 127) were examined pretreatment, immediately after treatment and 1 month and 3 months post-treatment with one of five antimicrobials. Isolates were tested for susceptibility to a range of antimicrobials using disc diffusion for each treatment group at different timepoints; the presence/absence of corresponding resistance genes was investigated using PCR assays. The impact of treatment group/timepoint and other risk factors on the presence of resistance [MDR, fluoroquinolone resistance, third-generation cephalosporin resistance (3GCR) and ESBL and AmpC production] was investigated using multilevel modelling. Samples with at least one AMR E. coli from selective/non-selective agar were classed as positive. Resistance was also assessed at the isolate level, determining the abundance of AMR from non-selective culture. RESULTS: Treatment with β-lactams or fluoroquinolones was significantly associated with the detection of 3GCR, AmpC-producing, MDR and/or fluoroquinolone-resistant E. coli, but not ESBL-producing E. coli, immediately after treatment. However, 1 month post-treatment, only amoxicillin/clavulanate was significantly associated with the detection of 3GCR; there was no significant difference at 3 months post-treatment for any antimicrobial compared with pretreatment samples. CONCLUSIONS: Our findings demonstrated that β-lactam and fluoroquinolone antibiotic usage is associated with increased detection of important phenotypic and genotypic AMR faecal E. coli following routine therapy in vet-visiting dogs. This has important implications for veterinary and public health in terms of antimicrobial prescribing and biosecurity protocols, and dog waste disposal.
引用
- Schmidt VM, Pinchbeck G, McIntyre KM, et al. Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli. J Antimicrob Chemother. 2018. PMID: 30215725. doi:10.1093/jac/dky352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。